logo
Plus   Neg
Share
Email

Palatin Reports FDA's Acceptance Of IND Application For PL-8177 - Quick Facts

Palatin Technologies, Inc. (PTN) announced the U.S. FDA has notified the company that it may proceed with its clinical investigation of subcutaneous injection PL-8177 as a potential treatment for patients with ulcerative colitis. The notice to proceed was received following Palatin's submission of an investigational new drug application for the program.

Palatin expects to commence a Phase 1 single and multiple ascending dose study in the current quarter.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Daily News, the struggling New York tabloid owned by Tronc, has reportedly laid off half of its newsroom staff on Monday. In an email send to staff, obtained by CNN, Tronc said "We are fundamentally restructuring the Daily News. We are reducing today the size of the editorial team by approximately... Papa John's International Inc.'s (PZZA) board has adopted a shareholder rights plan or poison pill strategy to prevent its controversial founder John Schnatter from gaining control of the pizza chain. Papa John's board announced the approval of a limited duration stockholder rights plan and declared... Ride-hailing companies Uber and Lyft have both suspended a driver for secretly live-streaming his passengers' journeys on video-sharing website Twitch, the St. Louis Post-Dispatch reported. The driver, Jason Gargac, live-streamed passengers' journeys and their interaction with him on Twitch, where viewers would comment on their appearance and conversations.
Follow RTT